Related Experiment Video
Updated: Sep 6, 2025

Author Spotlight: Unraveling the Molecular Mechanisms in PCO and Fibrosis Following Cataract Surgery
Published on: December 1, 2023
Toll-like receptor 3 gene regulates cataract-related mechanisms via the Jagged-1/Notch signaling pathway
Weiwei Xie1, Qihua Yu1, Layi Wang1
1Department of Ophthalmology, The Affiliated Ningbo Eye Hospital of Wenzhou Medical University, Ningbo, Zhejiang, China.
Abstract:
Epithelial-melancholy transition (EMT) is the main cause of organ fibrosis and a common pathogenetic mechanism in most cataracts. This study aimed to explore the molecular mechanism of Toll-like receptor (TLR)-3 in the occurrence and development of post-cataract EMT and to provide new ideas for the prevention and treatment of posterior capsule opacification (PCO). In the presence or absence of TLR3, the human lens epithelial cell (LEC) line, SRA01/04, was treated with the transforming growth factor (TGF)-β2. Cell counting kit-8 (CCK-8) and Transwell assays were used to analyze the cell proliferation, migration, and invasion. The expression levels of proteins and RNAs were detected by western blotting and quantitative polymerase chain reaction (qPCR) experiments. Functional gain and loss studies showed that TLR3 regulates the proliferation, migration, and invasion of LECs and EMT induced by TGF-β2. Moreover, TLR3 regulates the expression of Jagged-1, Notch-1, and Notch-3 These findings indicate that TLR3 prevents the progression of lens fibrosis by targeting the Jagged-1/Notch signaling pathway to regulate the proliferation, migration, and invasion of LECs, and TGF-β2-induced EMT. Therefore, the TLR3-Jagged-1/Notch signaling axis may be a potential therapeutic target for the treatment of fibrotic cataracts.
Insights
Toll-like receptor (TLR) 3 activation inhibits lens epithelial cell proliferation and migration, preventing fibrosis and posterior capsule opacification. This discovery highlights the TLR3-Jagged-1/Notch pathway as a potential therapeutic target for fibrotic cataracts.
Area of Science:
- Ophthalmology
- Cell Biology
- Immunology
Background:
- Epithelial-mesenchymal transition (EMT) drives organ fibrosis and is implicated in cataract pathogenesis.
- Posterior capsule opacification (PCO) is a common complication following cataract surgery, often linked to fibrosis.
Purpose of the Study:
- To investigate the role of Toll-like receptor (TLR) 3 in transforming growth factor-beta 2 (TGF-β2)-induced EMT in lens epithelial cells (LECs).
- To elucidate the molecular mechanism by which TLR3 influences LEC behavior and fibrosis.
- To identify potential therapeutic targets for fibrotic cataracts and PCO.
Main Methods:
- Human LEC line (SRA01/04) treated with TGF-β2 in the presence or absence of TLR3.
- Cell proliferation, migration, and invasion assessed using CCK-8 and Transwell assays.
- Protein and RNA expression analyzed via Western blotting and qPCR.
- Functional gain and loss studies performed.
Main Results:
- TLR3 modulates the proliferation, migration, and invasion of LECs.
- TLR3 regulates TGF-β2-induced EMT in LECs.
- TLR3 influences the expression of Jagged-1, Notch-1, and Notch-3, indicating regulation of the Jagged-1/Notch signaling pathway.
Conclusions:
- TLR3 plays a protective role against lens fibrosis by inhibiting TGF-β2-induced EMT via the Jagged-1/Notch signaling pathway.
- The TLR3-Jagged-1/Notch signaling axis represents a promising therapeutic target for treating fibrotic cataracts and preventing PCO.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
TGF - β Signaling Pathway
Hedgehog Signaling Pathway
The JAK-STAT Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Canonical Wnt Signaling Pathway

